Athena Philis‐Tsimikas

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

Thomas W. Martens, Roy W. Beck, Ryan Bailey et al. · JAMA · 2021 · 445 citations · Full text

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

Bernard Zinman, Vaishali Bhosekar, Robert S. Busch et al. · The Lancet Diabetes & Endocrinology · 2019 · 336 citations

Diabetes Management, Sglt-2 Inhibitor Therapy, Medicine +7

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes

Richard E. Pratley, Lauren Kanapka, Michael R. Rickels et al. · JAMA · 2020 · 334 citations · Full text

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes

Bernard Zinman, Athena Philis‐Tsimikas, Bertrand Cariou et al. · Diabetes Care · 2012 · 333 citations · Full text